Gilead Sciences Chief Commercial & Corporate Affairs Officer Settles RSUs with Tax Withholding

Executive Summary

On September 11, 2026, Johanna Mercier, Chief Commercial & Corporate Affairs Officer of Gilead Sciences, Inc. ($GILD), reported standard equity compensation activity executed on September 10, 2026. The transaction involved the vesting and settlement of 2,797 Restricted Stock Units (RSUs) into common stock, followed by the disposition of 1,347 shares at $144.81 per share to cover statutory tax withholding obligations.

Key Transaction Details

• RSU Conversion (Code M): 2,797 shares of Common Stock acquired upon the vesting of RSUs at $0.00 conversion price.
• Tax Withholding (Code F): 1,347 shares automatically surrendered to the issuer at $144.81 per share, representing a transaction value of $195,059.07.
• Net Change in Ownership: Net increase of 1,450 common shares.
• Post-Transaction Holdings: Johanna Mercier directly owns 119,684 shares of Gilead Sciences common stock and retains 25,054 unvested RSUs.

Market & Governance Implications

This filing reflects routine compensation vesting and mandatory tax withholding. Because the disposition was non-discretionary and solely executed to fulfill tax liabilities associated with RSU vesting, it does not indicate open-market selling or a change in insider sentiment.